Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-203 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating AD-203 for acute and chronic gastritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• AD-203

Snippet

Sponsor: Addpharma Inc. | Conditions: Acute Gastritis, Chronic Gastritis | Phase 3 | Status: COMPLETED